Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACHE | P22303 | 1/20 | 0.35 |
| ▸ | CDC25A | P30304 | 2/20 | 0.31 |
| ▸ | CDC25B | P30305 | 2/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17344796 | 0.73 | CA12 (0.47) | CDC25ACDC25B | |
| SCHEMBL17344793 | 0.71 | CDC25A (0.33) | CDC25ACDC25B | |
| SCHEMBL17344764 | 0.70 | PARP1 (0.50) | — | |
| SCHEMBL17349231 | 0.69 | ACHE (0.38) | ACHE | |
| SCHEMBL17344770 | 0.68 | PDPK1 (0.40) | — | |
| SCHEMBL17344773 | 0.67 | KDM4E (0.36) | CDC25ACDC25B | |
| SCHEMBL17344788 | 0.63 | NOS2 (0.33) | CDC25ACDC25B | |
| SCHEMBL3489535 | 0.62 | — | — | |
| SCHEMBL5702808 | 0.54 | PTPN1 (0.39) | ACHECDC25ACDC25B | |
| SCHEMBL4509523 | 0.54 | PNMT (0.39) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20150361093-A1 | HIV REPLICATION INHIBITOR | SHIONOGI & CO., LTD. (JP) | 2015-12-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150361093-A1 | HIV REPLICATION INHIBITOR | RTF2, REV1, PCNA | ACHE 3175/4885CDC25A 1053/4885CDC25B 1146/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.